awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47917650-1DDB2FB2-8320-41FD-AFB3-688134E32FD3
Q47917650-1DDB2FB2-8320-41FD-AFB3-688134E32FD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47917650-1DDB2FB2-8320-41FD-AFB3-688134E32FD3
First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI.
P2860
Q47917650-1DDB2FB2-8320-41FD-AFB3-688134E32FD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47917650-1DDB2FB2-8320-41FD-AFB3-688134E32FD3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d7c194bf9138a5999c348f220fc3e4e72f1936e
P2860
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial